BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 109 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q1 2016. The put-call ratio across all filers is 0.42 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $218,000 | -4.0% | 41,655 | +2.2% | 0.00% | 0.0% |
| Q2 2017 | $227,000 | -32.4% | 40,755 | +2.0% | 0.00% | -50.0% |
| Q1 2017 | $336,000 | +31.8% | 39,955 | -0.7% | 0.00% | 0.0% |
| Q4 2016 | $255,000 | +43.3% | 40,255 | 0.0% | 0.00% | +100.0% |
| Q3 2016 | $178,000 | +56.1% | 40,255 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $114,000 | +16.3% | 40,255 | +15.7% | 0.00% | 0.0% |
| Q1 2016 | $98,000 | -67.8% | 34,805 | +18.0% | 0.00% | -66.7% |
| Q4 2015 | $304,000 | +3.8% | 29,505 | +14.8% | 0.00% | 0.0% |
| Q3 2015 | $293,000 | -21.2% | 25,705 | +3.2% | 0.00% | -25.0% |
| Q2 2015 | $372,000 | +63.2% | 24,905 | -1.3% | 0.00% | +100.0% |
| Q1 2015 | $228,000 | -25.5% | 25,225 | +0.2% | 0.00% | -33.3% |
| Q4 2014 | $306,000 | +9.7% | 25,175 | -11.7% | 0.00% | 0.0% |
| Q3 2014 | $279,000 | -75.8% | 28,495 | -68.5% | 0.00% | -78.6% |
| Q2 2014 | $1,154,000 | +152.0% | 90,523 | +108.9% | 0.01% | +133.3% |
| Q1 2014 | $458,000 | +215.9% | 43,323 | +127.7% | 0.01% | +200.0% |
| Q4 2013 | $145,000 | +3.6% | 19,023 | -1.3% | 0.00% | 0.0% |
| Q3 2013 | $140,000 | +438.5% | 19,273 | +15.9% | 0.00% | – |
| Q2 2013 | $26,000 | – | 16,623 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 7,637,700 | $77,675,000 | 7.44% |
| Burrage Capital Management LLC | 864,916 | $8,796,000 | 7.13% |
| ORACLE INVESTMENT MANAGEMENT INC | 2,367,670 | $24,079,000 | 3.61% |
| HealthCor Management, L.P. | 4,886,440 | $49,695,000 | 1.76% |
| Ghost Tree Capital, LLC | 500,000 | $5,085,000 | 1.20% |
| Integral Health Asset Management, LLC | 400,000 | $4,068,000 | 1.16% |
| Lisanti Capital Growth, LLC | 472,520 | $4,806,000 | 0.62% |
| Parkman Healthcare Partners LLC | 244,680 | $2,488,000 | 0.58% |
| Baker Brothers Advisors | 12,710,818 | $129,269,000 | 0.56% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,605,380 | $26,497,000 | 0.56% |